SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-006795
Filing Date
2005-03-16
Accepted
2005-03-16 16:56:03
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2153708z10-k.htm 10-K 564619
2 EXHIBIT 10.43 a2153708zex-10_43.htm EX-10.43 198415
3 EXHIBIT 10.44 a2153708zex-10_44.htm EX-10.44 4511
4 EXHIBIT 21.1 a2153708zex-21_1.htm EX-21.1 1160
5 EXHIBIT 23.1 a2153708zex-23_1.htm EX-23.1 2451
6 EXHIBIT 31.1 a2153708zex-31_1.htm EX-31.1 6267
7 EXHIBIT 31.2 a2153708zex-31_2.htm EX-31.2 6226
8 EXHIBIT 32.1 a2153708zex-32_1.htm EX-32.1 2986
  Complete submission text file 0001047469-05-006795.txt   789097
Mailing Address 236 WEST CUMMINGS PARK WOBURN MA 01801
Business Address 236 WEST CUMMINGS PARK WOBURN MA 01801 6179326616
ANIKA THERAPEUTICS INC (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14027 | Film No.: 05686177
SIC: 2836 Biological Products, (No Diagnostic Substances)